Fulvimac Injection 5 ml belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.
Fulvimac Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Fulvimac Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Fulvimac Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Fulvimac Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulvimac Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Fulvimac Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulvimac Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulvimac Injection 5 ml.